About Bind Therapeutics
Bind Therapeutics is a company based in Cambridge (United States) founded in 2007. It operates as a B2B. Bind Therapeutics has raised $62.67 million across 6 funding rounds from investors including Flagship Pioneering, Arch Venture Partners and ROSNANO Group. The company has 103 employees as of December 31, 2015. Bind Therapeutics operates in a competitive market with competitors including Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Incyte, among others.
- Headquarter Cambridge, United States
- Employees 103 as on 31 Dec, 2015
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Bind Therapeutics, Inc
-
Annual Revenue
$15.4 M0as on Dec 31, 2015
-
Net Profit
-
EBITDA
-
Total Equity Funding
$62.67 M (USD)
in 6 rounds
-
Latest Funding Round
$8.7 M (USD), Series D
Feb 08, 2013
-
Investors
Flagship Pioneering
& 5 more
-
Employee Count
103
as on Dec 31, 2015
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Bind Therapeutics
Bind Therapeutics has successfully raised a total of $62.67M across 6 strategic funding rounds. The most recent funding activity was a Series D round of $8.7 million completed in February 2013. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 6
- Last Round Series D — $8.7M
-
First Round
First Round
(27 Nov 2007)
- Investors Count 6
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2013 | Amount | Series D - Bind Therapeutics | Valuation |
investors |
|
| Nov, 2011 | Amount | Series D - Bind Therapeutics | Valuation | Rusnano |
|
| Oct, 2011 | Amount | Debt – Conventional - Bind Therapeutics | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Bind Therapeutics
Bind Therapeutics has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include Flagship Pioneering, Arch Venture Partners and ROSNANO Group. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
ROSNANO Group is engaged in nanotechnology and microelectronics development.
|
Founded Year | Domain | Location | |
|
Venture capital firm focused on life science companies
|
Founded Year | Domain | Location | |
|
US focused venture capital firm
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Bind Therapeutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Bind Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Bind Therapeutics Comparisons
Competitors of Bind Therapeutics
Bind Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Incyte, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| domain | founded_year | HQ Location |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| domain | founded_year | HQ Location |
Targeted and immune-oncology drugs for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
Radiopharmaceuticals for oncology diagnostics and therapies are developed and marketed.
|
|
| domain | founded_year | HQ Location |
Small molecules are developed for cancer and skin disease treatments.
|
|
| domain | founded_year | HQ Location |
Cancer therapies are developed using selective pathway inhibitors.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Bind Therapeutics
Frequently Asked Questions about Bind Therapeutics
When was Bind Therapeutics founded?
Bind Therapeutics was founded in 2007.
Where is Bind Therapeutics located?
Bind Therapeutics is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.
Is Bind Therapeutics a funded company?
Bind Therapeutics is a funded company, having raised a total of $62.67M across 6 funding rounds to date. The company's 1st funding round was a Debt – Conventional of $4.75M, raised on Nov 27, 2007.
How many employees does Bind Therapeutics have?
As of Dec 31, 2015, the latest employee count at Bind Therapeutics is 103.
What is the annual revenue of Bind Therapeutics?
Annual revenue of Bind Therapeutics is $15.4M as on Dec 31, 2015.
What does Bind Therapeutics do?
Bind Therapeutics, based in Cambridge, focuses on healthcare and biotechnology, biotech, therapeutics, and nano-medicine. Develops targeted cancer therapeutics using advanced drug delivery nano-medicine platforms. The company prioritizes operational excellence, innovation, and customer-centric approaches for success. It continues to evolve, meeting industry challenges with strategic approaches.
Who are the top competitors of Bind Therapeutics?
Bind Therapeutics's top competitors include Moderna, Jazz Pharmaceuticals and Advanced Accelerator Applications.
Who are Bind Therapeutics's investors?
Bind Therapeutics has 6 investors. Key investors include Flagship Pioneering, Arch Venture Partners, ROSNANO Group, Polaris Partners, and NanoDimension.